NO20025893D0 - Veksthormon sekretagoga - Google Patents

Veksthormon sekretagoga

Info

Publication number: NO20025893D0
Authority: NO; Norway
Prior art keywords: growth hormone; hormone secretagogue; growth; secretion deficiency; hormone secretion
Prior art date: 2000-06-13

Application number

NO20025893A

Other languages

English (en)

Other versions

NO20025893L (no

NO323873B1 (no

Inventor

Jean Martinez

Jean-Alain Fehrentz

Vincent Guerlavais

Original Assignee

Zentaris Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-06-13

Filing date

2002-12-09

Publication date

2002-12-09

2002-12-09 Application filed by Zentaris Ag filed Critical Zentaris Ag

2002-12-09 Publication of NO20025893D0 publication Critical patent/NO20025893D0/no

2003-02-10 Publication of NO20025893L publication Critical patent/NO20025893L/no

2007-07-16 Publication of NO323873B1 publication Critical patent/NO323873B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/0212—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -N-C-N-C(=0)-, e.g. retro-inverso peptides
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
- C07K5/06034—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06008—Dipeptides with the first amino acid being neutral
- C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Orthopedic Medicine & Surgery (AREA)
Immunology (AREA)
Rheumatology (AREA)
Virology (AREA)
Obesity (AREA)
Crystallography & Structural Chemistry (AREA)
Hematology (AREA)
AIDS & HIV (AREA)
Urology & Nephrology (AREA)
Oncology (AREA)
Surgery (AREA)
Nutrition Science (AREA)
Communicable Diseases (AREA)
Dermatology (AREA)
Tropical Medicine & Parasitology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Indole Compounds (AREA)

NO20025893A 2000-06-13 2002-12-09 Veksthormon sekretagoga NO323873B1 (no)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US21132600P	2000-06-13	2000-06-13
US23492800P	2000-09-26	2000-09-26
PCT/EP2001/006717 WO2001096300A1 (en)	2000-06-13	2001-06-13	Growth hormone secretagogues

Publications (3)

Publication Number	Publication Date
NO20025893D0 true NO20025893D0 (no)	2002-12-09
NO20025893L NO20025893L (no)	2003-02-10
NO323873B1 NO323873B1 (no)	2007-07-16

Family

ID=26906052

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20025893A NO323873B1 (no)	2000-06-13	2002-12-09	Veksthormon sekretagoga

Country Status (29)

Country	Link
US (2)	US6861409B2 (no)
EP (1)	EP1289951B1 (no)
JP (2)	JP3522265B2 (no)
KR (1)	KR100825109B1 (no)
CN (1)	CN1232507C (no)
AR (1)	AR029941A1 (no)
AT (3)	ATE370119T1 (no)
AU (2)	AU2001266066B2 (no)
BG (3)	BG66130B1 (no)
BR (1)	BRPI0111591B8 (no)
CA (1)	CA2407659C (no)
CY (2)	CY1107710T1 (no)
CZ (2)	CZ305279B6 (no)
DE (3)	DE60130025T2 (no)
DK (3)	DK1524272T3 (no)
ES (3)	ES2250416T3 (no)
FR (1)	FR19C1044I2 (no)
HU (1)	HU229233B1 (no)
IL (2)	IL153067A0 (no)
MX (1)	MXPA02011899A (no)
NL (1)	NL300999I2 (no)
NO (1)	NO323873B1 (no)
NZ (1)	NZ522280A (no)
PL (1)	PL216676B1 (no)
PT (2)	PT1524272E (no)
RU (1)	RU2270198C2 (no)
SK (1)	SK287169B6 (no)
TW (2)	TW200831076A (no)
WO (1)	WO2001096300A1 (no)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6861409B2 (en) *	2000-06-13	2005-03-01	Zentaris Ag	Growth hormone secretagogues
CU23157A1 (es) *	2001-01-03	2006-07-18	Ct Ingenieria Genetica Biotech	COMPOSICION FARMACéUTICA PARA EL TRATAMIENTO DEL DANO TISULAR DEBIDO A FALTA DE IRRIGACION SANGUINEA ARTERIAL
US7476653B2 (en)	2003-06-18	2009-01-13	Tranzyme Pharma, Inc.	Macrocyclic modulators of the ghrelin receptor
US7034050B2 (en) *	2004-04-28	2006-04-25	Romano Deghenghi	Pseudopeptides growth hormone secretagogues
EP1919492B1 (en) *	2005-07-22	2013-03-06	Ipsen Pharma	Growth hormone secretagogues
EP1757290A1 (en)	2005-08-16	2007-02-28	Zentaris GmbH	Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors
GB0603295D0 (en)	2006-02-18	2006-03-29	Ardana Bioscience Ltd	Methods and kits
CU23558A1 (es)	2006-02-28	2010-07-20	Ct Ingenieria Genetica Biotech	Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento
US7763707B2 (en) *	2006-03-13	2010-07-27	Liat Mintz	Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation
US9371297B2 (en)	2007-02-09	2016-06-21	Ocera Therapeutics, Inc.	Macrocyclic ghrelin receptor modulators and methods of using the same
EP2103602A1 (en)	2008-03-17	2009-09-23	AEterna Zentaris GmbH	Novel 1,2,4-triazole derivatives and process of manufacturing thereof
US8431642B2 (en) *	2008-06-09	2013-04-30	Exxonmobil Chemical Patents Inc.	Polyolefin adhesive compositions and articles made therefrom
EP2431035A1 (en)	2010-09-16	2012-03-21	Æterna Zentaris GmbH	Novel Triazole Derivatives with Improved Receptor Activity and Bioavailability Properties as Ghrelin Antagonists of Growth Hormone Secretagogue Receptors
US8747921B2 (en)	2012-09-19	2014-06-10	Quality Ip Holdings, Inc.	Methods for improving health in humans
US8747922B2 (en)	2012-09-19	2014-06-10	Quality Ip Holdings, Inc.	Methods and compositions for increasing sex steroids and growth hormones
US10300101B2 (en)	2012-09-19	2019-05-28	Quality IP Holdings, LLC	Methods and compositions for enhancing or maintaining fertility
US9198889B2 (en)	2012-09-19	2015-12-01	Quality IP Holdings, LLC	Methods for treating post-traumatic stress disorder
US9066953B2 (en)	2012-09-20	2015-06-30	Quality IP Holdings, LLC	Methods for increasing endurance and fat metabolism in humans
US10292957B2 (en)	2012-09-20	2019-05-21	Quality IP Holdings, LLC	Compositions and methods for treating fibromyalgia
US8747923B2 (en)	2012-09-20	2014-06-10	Quality Ip Holdings, Inc.	Methods for improving health in canines
US8715752B2 (en)	2012-09-20	2014-05-06	Quality Ip Holdings, Inc.	Compositions for increasing human growth hormone levels
CN104853778A (zh)	2012-10-24	2015-08-19	第一三共株式会社	用于肌萎缩性侧索硬化的治疗剂
CN105330720A (zh) *	2014-06-06	2016-02-17	深圳翰宇药业股份有限公司	一种制备马昔瑞林的方法
UA123865C2 (uk) *	2015-09-21	2021-06-16	Люмос Фарма, Інк	Визначення та лікування дефіциту гормону росту
US10894072B2 (en)	2017-02-13	2021-01-19	IP Quality Holdings, LLC	Compositions and methods for treating fibromyalgia
US10288629B1 (en)	2017-12-19	2019-05-14	Aeterna Zentaris, Inc.	Method of assessing growth hormone deficiency in humans by a macimorelin containing composition
CA3185680A1 (en)	2020-07-22	2022-01-27	Nicola Ammer	A screening method for diagnosing growth hormone deficiency in pediatric patients by using macimorelin

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4880778A (en) *	1986-05-12	1989-11-14	Eastman Kodak Company	Combinations having synergistic growth hormone releasing activity and methods for use thereof
ATE122357T1 (de) *	1988-01-28	1995-05-15	Polygen Holding Corp	Polypeptide mit hormonwachstumsbefreiender wirkung.
US5536814A (en) *	1993-09-27	1996-07-16	La Jolla Cancer Research Foundation	Integrin-binding peptides
WO1995014666A1 (en) *	1993-11-24	1995-06-01	Merck & Co., Inc.	Indolyl group containing compounds and the use thereof to promote the release of growth hormone(s)
US5798337A (en) *	1994-11-16	1998-08-25	Genentech, Inc.	Low molecular weight peptidomimetic growth hormone secretagogues
US6025471A (en) *	1998-06-03	2000-02-15	Deghenghi; Romano	Diazaspiro, azepino and azabicyclo therapeutic peptides
US6861409B2 (en) *	2000-06-13	2005-03-01	Zentaris Ag	Growth hormone secretagogues

2001
- 2001-06-13 US US09/880,498 patent/US6861409B2/en not_active Expired - Lifetime
- 2001-06-13 AT AT03075950T patent/ATE370119T1/de active
- 2001-06-13 SK SK1756-2002A patent/SK287169B6/sk not_active IP Right Cessation
- 2001-06-13 BR BRPI0111591A patent/BRPI0111591B8/pt not_active IP Right Cessation
- 2001-06-13 DK DK05075086T patent/DK1524272T3/da active
- 2001-06-13 RU RU2002135312/04A patent/RU2270198C2/ru not_active IP Right Cessation
- 2001-06-13 DK DK03075950T patent/DK1344773T3/da active
- 2001-06-13 AR ARP010102827A patent/AR029941A1/es active IP Right Grant
- 2001-06-13 AU AU2001266066A patent/AU2001266066B2/en not_active Expired
- 2001-06-13 DE DE60130025T patent/DE60130025T2/de not_active Expired - Lifetime
- 2001-06-13 KR KR1020027016614A patent/KR100825109B1/ko not_active Expired - Lifetime
- 2001-06-13 DE DE60128494T patent/DE60128494T2/de not_active Expired - Lifetime
- 2001-06-13 AT AT01943504T patent/ATE302181T1/de active
- 2001-06-13 ES ES01943504T patent/ES2250416T3/es not_active Expired - Lifetime
- 2001-06-13 NZ NZ522280A patent/NZ522280A/en not_active IP Right Cessation
- 2001-06-13 DK DK01943504T patent/DK1289951T3/da active
- 2001-06-13 HU HU0302026A patent/HU229233B1/hu active IP Right Revival
- 2001-06-13 PL PL363081A patent/PL216676B1/pl unknown
- 2001-06-13 CZ CZ2011-585A patent/CZ305279B6/cs not_active IP Right Cessation
- 2001-06-13 DE DE60112753T patent/DE60112753T2/de not_active Expired - Lifetime
- 2001-06-13 CA CA2407659A patent/CA2407659C/en not_active Expired - Lifetime
- 2001-06-13 WO PCT/EP2001/006717 patent/WO2001096300A1/en not_active Ceased
- 2001-06-13 PT PT05075086T patent/PT1524272E/pt unknown
- 2001-06-13 ES ES05075086T patent/ES2288724T3/es not_active Expired - Lifetime
- 2001-06-13 IL IL15306701A patent/IL153067A0/xx unknown
- 2001-06-13 EP EP01943504A patent/EP1289951B1/en not_active Expired - Lifetime
- 2001-06-13 CN CNB018104916A patent/CN1232507C/zh not_active Expired - Lifetime
- 2001-06-13 AT AT05075086T patent/ATE362472T1/de active
- 2001-06-13 PT PT03075950T patent/PT1344773E/pt unknown
- 2001-06-13 MX MXPA02011899A patent/MXPA02011899A/es active IP Right Grant
- 2001-06-13 AU AU6606601A patent/AU6606601A/xx active Pending
- 2001-06-13 ES ES03075950T patent/ES2292900T3/es not_active Expired - Lifetime
- 2001-06-13 JP JP2002510444A patent/JP3522265B2/ja not_active Expired - Lifetime
- 2001-06-13 CZ CZ20024095A patent/CZ303173B6/cs not_active IP Right Cessation
- 2001-08-01 TW TW097111056A patent/TW200831076A/zh unknown
- 2001-08-01 TW TW090114317A patent/TWI305529B/zh not_active IP Right Cessation
2002
- 2002-11-24 IL IL153067A patent/IL153067A/en active IP Right Grant
- 2002-12-09 NO NO20025893A patent/NO323873B1/no not_active IP Right Cessation
- 2002-12-12 BG BG107379A patent/BG66130B1/bg unknown
2003
- 2003-06-02 JP JP2003156884A patent/JP4932132B2/ja not_active Expired - Lifetime
2004
- 2004-05-04 US US10/837,620 patent/US7297681B2/en not_active Expired - Lifetime
2007
- 2007-08-07 CY CY20071101051T patent/CY1107710T1/el unknown
- 2007-11-08 CY CY20071101443T patent/CY1107793T1/el unknown
2010
- 2010-07-21 BG BG10110708A patent/BG66216B1/bg unknown
- 2010-10-18 BG BG10110771A patent/BG66217B1/bg unknown
2019
- 2019-07-05 NL NL300999C patent/NL300999I2/nl unknown
- 2019-07-08 FR FR19C1044C patent/FR19C1044I2/fr active Active

Also Published As

Publication number	Publication date
BG107379A (bg)	2003-09-30
MXPA02011899A (es)	2003-04-22
BG66130B1 (bg)	2011-06-30
US7297681B2 (en)	2007-11-20
ES2292900T3 (es)	2008-03-16
DE60112753T2 (de)	2006-06-29
BR0111591A (pt)	2003-05-06
US20040229823A1 (en)	2004-11-18
CN1232507C (zh)	2005-12-21
RU2270198C2 (ru)	2006-02-20
FR19C1044I2 (fr)	2020-07-24
ES2250416T3 (es)	2006-04-16
DK1344773T3 (da)	2007-12-27
KR100825109B1 (ko)	2008-04-25
JP2003335752A (ja)	2003-11-28
JP4932132B2 (ja)	2012-05-16
NO20025893L (no)	2003-02-10
DE60128494T2 (de)	2008-01-17
DE60130025T2 (de)	2008-05-15
DE60128494D1 (de)	2007-06-28
CA2407659C (en)	2010-11-09
CA2407659A1 (en)	2001-12-20
BG66216B1 (bg)	2012-05-31
US6861409B2 (en)	2005-03-01
PL216676B1 (pl)	2014-05-30
JP3522265B2 (ja)	2004-04-26
WO2001096300A1 (en)	2001-12-20
EP1289951A1 (en)	2003-03-12
CZ303173B6 (cs)	2012-05-16
FR19C1044I1 (no)	2019-09-08
DK1289951T3 (da)	2005-12-19
ATE370119T1 (de)	2007-09-15
PT1524272E (pt)	2007-07-25
IL153067A0 (en)	2003-06-24
ES2288724T3 (es)	2008-01-16
CY1107793T1 (el)	2013-06-19
KR20030007889A (ko)	2003-01-23
TW200831076A (en)	2008-08-01
PL363081A1 (en)	2004-11-15
BG110708A (en)	2010-12-30
SK17562002A3 (sk)	2003-05-02
AU6606601A (en)	2001-12-24
HUP0302026A2 (hu)	2003-09-29
AR029941A1 (es)	2003-07-23
EP1289951B1 (en)	2005-08-17
HU229233B1 (en)	2013-09-30
US20020165343A1 (en)	2002-11-07
NZ522280A (en)	2004-09-24
CN1431998A (zh)	2003-07-23
PT1344773E (pt)	2007-11-27
HK1054224A1 (en)	2003-11-21
BG110771A (bg)	2011-03-31
AU2001266066B2 (en)	2005-06-30
CZ305279B6 (cs)	2015-07-15
BG66217B1 (bg)	2012-05-31
TWI305529B (en)	2009-01-21
DK1524272T3 (da)	2007-09-03
CY1107710T1 (el)	2013-04-18
DE60130025D1 (de)	2007-09-27
DE60112753D1 (de)	2005-09-22
CZ20024095A3 (cs)	2003-05-14
ATE302181T1 (de)	2005-09-15
SK287169B6 (sk)	2010-02-08
HUP0302026A3 (en)	2009-01-28
BR0111591B1 (pt)	2014-02-04
NL300999I2 (nl)	2019-08-28
BRPI0111591B8 (pt)	2021-05-25
JP2004503536A (ja)	2004-02-05
ATE362472T1 (de)	2007-06-15
IL153067A (en)	2010-05-31
NO323873B1 (no)	2007-07-16
NL300999I1 (nl)	2019-07-17

Publication	Publication Date	Title
NO20025893D0 (no)	2002-12-09	Veksthormon sekretagoga
EA200101166A1 (ru)	2002-06-27	Ингибиторы металлопротеаз
JO2282B1 (en)	2005-09-12	Oxazole derivatives
EA200401345A1 (ru)	2005-08-25	Лечение гастропареза
EA200300026A1 (ru)	2003-04-24	Аналоги глюкагоноподобного пептида-1
UA92355C2 (en)	2010-10-25	urn:schemas-microsoft-com:office:smarttags2,4-DIAMINO-PYRIMIDINES USED AS AURORAINHIBITORS
MY135841A (en)	2008-07-31	Novel benzodioxoles
ATE297922T1 (de)	2005-07-15	Isoindolin-1-on als glukokinaseaktivatoren
YU65502A (sh)	2005-11-28	Supstituisani beta-karbolini sa ikb-kinaza inhibirajućim dejstvom
MXPA02011411A (es)	2003-04-25	Inhibidores de proteasa de serina.
JO2475B1 (en)	2009-01-20	Glucokinase stimulants
ES2356883A1 (es)	2011-04-14	Composicion para el tratamiento del dolor y/o la inflamacion.
TW200626558A (en)	2006-08-01	Indazolone derivatives
MXPA02007099A (es)	2004-08-23	Compuestos de tiazola, imidazola y oxazola y tratamientos de desordenes asociados con la maduracion de la proteina.
EA200601747A1 (ru)	2007-04-27	Три(цикло)замещённые амидные соединения
ATE303384T1 (de)	2005-09-15	1-biaryl-1,8-naphthyridin-4-one als phosphodieseterase-inhibitoren
GB0030303D0 (en)	2001-01-24	Compounds
GB0030306D0 (en)	2001-01-24	Compounds
GB0003025D0 (en)	2000-03-29	Novel compounds
NO984950L (no)	1998-12-21	Forbindelser med veksthormonfrigj°rende egenskaper
SE9802793D0 (sv)	1998-08-21	New compounds
MY141020A (en)	2010-02-25	Novel pparalpha and ppargamma agonists
MXPA05014184A (es)	2006-03-09	Utilizacion de acido hialuronico para la preparacion de composiciones para el tratamiento de aftas en la cavidad oral.
DE60127131D1 (de)	2007-04-19	Tricyclische imidazopyridine
TR200102514T2 (tr)	2002-04-22	COPD tedavisi için metod

Legal Events

Date	Code	Title	Description
2012-08-20	CHAD	Change of the owner's name or address (par. 44 patent law, par. patentforskriften)	Owner name: AETERNA ZENTARIS GMBH, DE
2021-07-12	MK1K	Patent expired